U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668193) titled 'GlaukomAI: Clinical Validation of an AI System for Early Glaucoma Screening' on June 19.
Brief Summary: Glaucoma is one of the leading causes of irreversible blindness worldwide. Early diagnosis is crucial to prevent vision loss, but current diagnostic pathways require multiple specialist visits and tests, leading to long waiting times and delayed diagnosis.
This study aims to evaluate the accuracy of GlaukomAI, an artificial intelligence (AI)-based software that analyzes fundus photographs of the eye to detect glaucoma at an early stage.
The study is conducted at IRCCS Fondazione G. B. Bietti (Rome, Italy) and is structured in tw...